Abstract
Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
Miguel A González-Gay, Ali H Hajeer, Carlos García-Porrúa, Adele Dababneh, Wendy Thomson, William E R Ollier and Derek L Mattey
The Journal of Rheumatology February 2002, 29 (2) 271-275;
Miguel A González-Gay
Ali H Hajeer
Carlos García-Porrúa
Adele Dababneh
Wendy Thomson
William E R Ollier
In this issue
Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
Miguel A González-Gay, Ali H Hajeer, Carlos García-Porrúa, Adele Dababneh, Wendy Thomson, William E R Ollier, Derek L Mattey
The Journal of Rheumatology Feb 2002, 29 (2) 271-275;
Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
Miguel A González-Gay, Ali H Hajeer, Carlos García-Porrúa, Adele Dababneh, Wendy Thomson, William E R Ollier, Derek L Mattey
The Journal of Rheumatology Feb 2002, 29 (2) 271-275;